Page 3 - Jb Chemicals & Pharmaceuticals

MARKET WRAP: Sensex settles 178 pts higher; defense stocks rally up to 12%

All that happened in the markets today

KKR to acquire controlling stake in JB Chemicals for Rs 3,750 crore

The total deal size thus will be around $500 mn or around Rs 3,750 crore

JB Chemicals gains 4%, nears 52-wk high as PE firm KKR to acquire 54% stake

After this transaction, an open offer will be launched to acquire 20.93 million fully paid-up equity shares of JB Chemicals, representing 26 per cent of equity.

Top headlines: States on GST compensation, Emami questions HUL & more

From states divided on alternative GST compensation, Emami questioning changing of 'Fair and Handsome' name to startups helping tenant amid Covid-19, here are the top headlines of the day

JB Chemicals & Pharma, Syngene International hit all-time highs

The stock of Syngene International has soared 24 per cent during the past month, as against a 2 per cent rise in the S&P BSE Sensex.

Covid-19 lockdown: After April shock, drug sales improve in May

Till May 15, the overall inventory was 39 days, compared to 43 days in first half of the previous month

Antiviral drugs see demand surge in India, but segment declines 5.5%

Data from market research firm AIOCD-AWACS shows that sales of oseltamivir (common brand Tamiflu), used against the influenza virus and also for swine flu, went up by 35.8 per cent in April

Lockdown serves domestic pharma the bitter pill: April growth slips

Lack of fresh prescriptions drags growth in acute therapies

Antibiotic sales drive domestic pharma mkt down 11.2% in lockdown-hit April

Sale of anti-infectives (11% of domestic pharma market) fell by 21.5%, while gynaecological and dermatological drugs fell by about 23%

JB Chemicals surges 11%, hits new high on report of PE firms eyeing stake

In the past one month, the stock rallied 39 per cent against 15 per cent rise in the S&P BSE Sensex

JB Chemicals surges 31% in eight days; stock nears record high

On April 1, the SC set aside the NGT order directing revocation of environmental clearance and closure of the company's bulk drugs Unit at Panoli, Gujarat

JB Chemicals nears record high in weak market, rebounds 8% from day's low

In the past three months, JB Chemicals & Pharma has outpaced the market by surging 48 per cent against 7.8 per cent decline in the S&P BSE Sensex

JB Chemicals gains 7% as board mulls share buyback plan

The stock of JB Chemicals has underperformed the market since it touched its recent high of Rs 405 on September 13, 2019.

USFDA wraps up inspection of JB Chemicals Panoli unit with no observations

JB Chemicals & Pharmaceuticals Wednesday said the US health regulator has concluded inspection of its manufacturing facility at Panoli in Gujarat without any observations. The US Food and Drug Administration (USFDA) has concluded inspection of company's newly set-up and commissioned solid oral dosage forms formulations manufacturing facility at Panoli, Gujarat, JB Chemicals & Pharmaceuticals said in a BSE filing. "At the end of inspection, no objectionable observations were found and hence no form 483 was issued," it stated. The said inspection was carried out from June 24-28, 2019, the company said. A Form 483, is issued by the USFDA to notify a company's management of any objectionable condition at its manufacturing facility. The form is issued after completing the inspection. JB Chemicals & Pharmaceuticals said this facility has capacity of two billion tablets per annum, which is expandable to nine billion tablets per annum. The company said new facility will augment ...

JB Chemicals surges 12% as board mulls share buyback proposal

The stock rallied 12% to Rs 338 on the BSE in intra-day trade after the company announced that its board will meet on August 31, to consider a share buyback proposal.

JB Chemicals & Pharmaceuticals Q1 net up 26% at Rs 49.85 crore

Shares of JB Chemicals & Pharmaceuticals were trading at Rs 346.70 per scrip on BSE

JB Chemicals hit lifetime high post Q1 results

The stock surged 14% to Rs 357, also its lifetime high on the BSE, on back of heavy volumes.

JB Chemicals surges on USFDA approval for Panoli tablet manufacturing facility

The stock rallied 11% to Rs 261 on the BSE on back of heavy volumes.